Health
Humoral and Cellular Response Following Vaccination With the BNT162b2 mRNA COVID-19 Vaccine in Patients Affected by Primary Immunodeficiencies – DocWire News
Front Immunol. 2021 Oct 4;12:727850. doi: 10.3389/fimmu.2021.727850. eCollection 2021.ABSTRACTMass SARS-Cov-2 vaccination campaign…
Front Immunol. 2021 Oct 4;12:727850. doi: 10.3389/fimmu.2021.727850. eCollection 2021.
ABSTRACT
Mass SARS-Cov-2 vaccination campaign represents the only strategy to defeat the global pandemic we are facing. Immunocompromised patients represent a vulnerable…
Continue Reading
-
Noosa News19 hours agoFamily pleads for help after 17-year-old Pheobe Bishop disappears in Bundaberg before flight
-
Business20 hours agoASX 200 lifts on the RBA’s latest interest rate call
-
Noosa News23 hours agoNo conviction recorded for teen behind attack on Peter Dutton’s office
-
Noosa News24 hours agoMan who allegedly stole children’s underwear charged with 28 offences